German watchdog calls for direct comparison of cancer immunotherapies
January 15, 2018 at 11:41 AM EST
FRANKFURT, Jan 15 (Reuters) - Germany's drug assessment body has criticised a lack of data directly comparing drugs in a promising new class of cancer immunotherapy, saying physicians could be overwhelmed or misled by the available information.